Ryvu Therapeutics S.A.
RVU.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -PLN 111,435 | -PLN 92,112 | -PLN 83,782 | -PLN 77,535 |
| Dep. & Amort. | PLN 10,495 | PLN 10,971 | PLN 12,900 | PLN 12,561 |
| Deferred Tax | PLN 0 | PLN 0 | -PLN 22,184 | -PLN 22,999 |
| Stock-Based Comp. | PLN 0 | PLN 0 | PLN 22,184 | PLN 22,999 |
| Change in WC | -PLN 16,444 | -PLN 14,275 | PLN 66,231 | -PLN 15,348 |
| Other Non-Cash | -PLN 12,095 | PLN 10,866 | PLN 25,970 | PLN 22,454 |
| Operating Cash Flow | -PLN 129,479 | -PLN 84,550 | PLN 21,319 | -PLN 57,868 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -PLN 5,903 | -PLN 8,579 | -PLN 9,287 | -PLN 11,982 |
| Net Acquisitions | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Inv. Purchases | PLN 0 | -PLN 192,610 | -PLN 528 | -PLN 4,994 |
| Inv. Sales/Matur. | PLN 0 | PLN 0 | PLN 4,994 | PLN 24,969 |
| Other Inv. Act. | PLN 143,068 | PLN 5,648 | PLN 5,511 | PLN 61 |
| Investing Cash Flow | PLN 137,165 | -PLN 195,541 | PLN 690 | PLN 8,055 |
| Financing Activities | – | – | – | – |
| Debt Repay. | PLN 94,656 | -PLN 620 | -PLN 702 | -PLN 791 |
| Stock Issued | PLN 0 | PLN 250,284 | PLN 0 | PLN 237 |
| Stock Repurch. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Dividends Paid | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Fin. Act. | -PLN 447 | -PLN 1,138 | -PLN 1,753 | -PLN 2,616 |
| Financing Cash Flow | PLN 94,209 | PLN 240,833 | -PLN 2,455 | -PLN 3,170 |
| Forex Effect | PLN 239 | -PLN 4,720 | -PLN 872 | PLN 0 |
| Net Chg. in Cash | PLN 102,134 | -PLN 43,978 | PLN 18,681 | -PLN 52,983 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | PLN 57,939 | PLN 101,917 | PLN 83,236 | PLN 136,218 |
| End Cash | PLN 160,073 | PLN 57,939 | PLN 101,917 | PLN 83,236 |
| Free Cash Flow | -PLN 135,382 | -PLN 88,114 | PLN 12,032 | -PLN 69,850 |